|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61L 31/16 | |
| A61L 31/06 |
| (11) | Number of the document | 1735027 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05821172.3 |
| Date of filing the European patent application | 2005-04-08 | |
| (97) | Date of publication of the European application | 2006-12-27 |
| (45) | Date of publication and mention of the grant of the patent | 2012-06-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/012121 |
| Date | 2005-04-08 |
| (87) | Number | WO 2006/036202 |
| Date | 2006-04-06 |
| (30) | Number | Date | Country code |
| 826441 | 2004-04-15 | US |
| (72) |
HUGHES, Patrick, US
OLEJNIK, Orest, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | STABILIZED BIODEGRADABLE NEUROTOXIN IMPLANTS |
| STABILIZED BIODEGRADABLE NEUROTOXIN IMPLANTS |